Alerts will be sent to your verified email
Verify Email
TRABI
|
Transgene Biotek
|
Tejnaksh Healthcare
|
Medinova Diagnostic
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-39.86 % | 10.88 % | -30.99 % |
|
5yr average Equity Multiplier
|
9.29 | 1.46 | -0.78 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.48 | 2.63 |
|
5yr Avg Net Profit Margin
|
-67187.68 % | 15.96 % | 13.18 % |
|
Price to Book
|
3.49 | 1.51 | 0.0 |
|
P/E
|
0.0 | 16.58 | 19.42 |
|
5yr Avg Cash Conversion Cycle
|
65.65 Days | -56.42 Days | -858.85 Days |
|
Inventory Days
|
866.48 Days | 20.02 Days | 4.43 Days |
|
Days Receivable
|
13.05 Days | 31.48 Days | 20.26 Days |
|
Days Payable
|
1913.74 Days | 141.3 Days | 997.21 Days |
|
5yr Average Interest Coverage Ratio
|
-24.4 | 5.93 | 4.07 |
|
5yr Avg ROCE
|
-5.18 % | 13.18 % | 124.73 % |
|
5yr Avg Operating Profit Margin
|
-5270.55 % | 30.73 % | 24.48 % |
|
5 yr average Debt to Equity
|
0.8 | 0.32 | -0.98 |
|
5yr CAGR Net Profit
|
-42.99 % | -3.16 % | n/a |
|
5yr Average Return on Assets
|
-4.99 % | 7.4 % | 36.96 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
23.64 % | 73.83 % | 62.14 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Transgene Biotek
|
Tejnaksh Healthcare
|
Medinova Diagnostic
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|